Northern Trust’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Northern Trust’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-60,000	Closed	-$6K	–	4266
2016 Q3	$6K	Hold	60,000	–	–	﹤0.01%	4151
2016 Q2	$22K	Hold	60,000	–	–	﹤0.01%	4111
2016 Q1	$23K	Hold	60,000	–	–	﹤0.01%	4121
2015 Q4	$23K	Hold	60,000	–	–	﹤0.01%	4157
2015 Q3	$35K	Buy	+60,000	New	+$30.7K	﹤0.01%	4134

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Northern Trust's PVCT Position: Q4 2016 in Review

Northern Trust sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 60,000 shares — an estimated $6K sold.

Northern Trust first reported a position in PVCT in Q3 2015 and held it in 5 quarters. The position peaked at $35K in Q3 2015. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Northern Trust reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Northern Trust sold 60,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $6K.
Northern Trust first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q3 2015 and held it in 5 quarters.
Northern Trust's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $35K in Q3 2015.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.